The Bakersfield Californian15d
FDA Approval of Eli Lilly’s Omvoh for Crohn’s Disease Adds a New Option, but Uptake May be ...
EXTON, PA, Jan. 31, 2025 (GLOBE NEWSWIRE) -- The FDA's approval of Eli Lilly’s Omvoh for Crohn’s disease marks a significant milestone as the therapy becomes the second IL-23 inhibitor ...
Finanzen15d
Rushil Decor: Das sind die jüngsten Quartalszahlen
Rushil Decor hat am 28.01.2025 das Zahlenwerk zum am 31.12.2024 ausgelaufenen Quartal vorgelegt. Das Ergebnis je Aktie lag bei 0,42 INR, nach 0,430 INR im Vorjahresvergleich. Auf der Umsatzseite ...
Finanzen15d
Erste Schätzungen: Yamazaki Baking stellt Zahlen zum jüngsten Quartal vor
Yamazaki Baking wird voraussichtlich am 14.02.2025 die Bilanz zum am 31.12.2024 abgelaufenen Quartal präsentieren. 3 Analysten erwarten beim EPS im Schnitt einen Gewinn von 44,83 JPY je Aktie.
Healthline16d
Omvoh Interactions: Alcohol, Medications, and Others
Omvoh (mirikizumab-mrkz) has potential interactions with certain vaccines and health conditions. These interactions could cause harmful effects in some people. Omvoh is used in adults to treat ...
Yahoo News UK16d
'I'm a pilot – you should never fly if you have one common health problem'
You may not see anything wrong with flying when you're feeling a bit run down, but a pilot explained why it's a bad idea. Captain Jaimes García, who has more than 156,000 followers on TikTok, shared a ...
Pharm Exec17d
Treating Disruptive Symptom’s in Crohn’s Patients: Q&A with Mark Genovese, MD
The senior vice president at Lilly Immunology Development discusses recent developments with Omvoh. The European Medicines Agency’s Committee for Medicinal Products for Human Use recently issued a ...
Ibj.com17d
OrthoIndy promotes Lavery to president
Just weeks after unveiling big merger plans, OrthoIndy announced Thursday that Dr. Matthew Lavery has been promoted to president at the Indianapolis-based orthopedic practice. Effective Monday ...
Ibj.com19d
Lilly’s Omvoh part of company’s expansion into inflammatory bowel disease treatment
Eli Lilly and Co.’s approval for Omvoh to treat moderate to severe Crohn’s disease in adults marks the Indianapolis company’s growing presence in the treatment of inflammatory bowel disease.
Monthly Prescribing Reference19d
Leqembi Monthly IV Maintenance Dosing Approved for Early Alzheimer Disease
Modeling simulations predict that transitioning to once every 4 weeks of lecanemab after 18 months will maintain clinical and biomarker therapy benefits. The Food and Drug Administration (FDA) has ...
Medical News Today22d
Wearable devices like Fitbit can predict IBD flares 7 weeks in advance
Share on Pinterest Wrist-worn devices could give advance notice of when the wearer might experience an IBD flare. Image credit: Studio Marmellata/Stocksy. For people with the unpredictable ...
Medical News Today23d
Omvoh interactions: Alcohol, medications, and other factors
Omvoh has possible interactions with certain vaccines. Examples include the chickenpox vaccine and the nasal spray flu vaccine (FluMist). Talk with your doctor to avoid potentially harmful effects ...